Risk Factors for Severe Morbidity and Mortality in Mothers and Neonates (KIPMAT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01757028 |
Recruitment Status : Unknown
Verified December 2014 by University of Oxford.
Recruitment status was: Recruiting
First Posted : December 28, 2012
Last Update Posted : December 19, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Maternal and Newborn Health |
Study Type : | Observational |
Estimated Enrollment : | 4600 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Risk Factors for Severe Morbidity and Mortality in Mothers and Neonates |
Study Start Date : | January 2010 |
Estimated Primary Completion Date : | December 2015 |
Estimated Study Completion Date : | December 2015 |
- Maternal mortality [ Time Frame: At delivery and follow up through DHS to 42 days ]Determine the effects of risk factors and obstetric events on maternal deaths (to 42 days).
- Perinatal mortality [ Time Frame: To 7 days post delivery ]Determine the effects of risk factors and obstetric events on perinatal mortality (stillbirth and deaths to 7 days of life); infant mortality to 60 days
- Maternal and Newborn long term survival [ Time Frame: ongoing ]Follow up to 2 years after delivery
- Maternal morbidity [ Time Frame: During admission (about 3 days) ]Life threatening events and maternal conditions at delivery
- Neonatal morbidity [ Time Frame: During admission (approx 2 weeks if admitted) ]Neonatal morbidity in terms of admission to the paediatric ward (and diagnosis).
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- All mothers admitted for delivery at Kilifi District Hospital (KDH), Kilifi, Kenya
Exclusion Criteria:
- Consent refusal

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01757028
Contact: James A Berkley | jberkley@kemri-wellcome.org | ||
Contact: Anna C Seale | aseale@kemri-wellcome.org |
Kenya | |
Kilifi District Hospital | Recruiting |
Kilifi, Coast, Kenya | |
Principal Investigator: James A Berkley | |
Principal Investigator: Anna C Seale |
Responsible Party: | University of Oxford |
ClinicalTrials.gov Identifier: | NCT01757028 |
Other Study ID Numbers: |
B9RPET0 |
First Posted: | December 28, 2012 Key Record Dates |
Last Update Posted: | December 19, 2014 |
Last Verified: | December 2014 |
Maternal and newborn health Africa |